dc.contributor.author | Dorta Gorrín, Alexis | es_ES |
dc.contributor.author | Navas Méndez, Jesús | es_ES |
dc.contributor.author | Gozalo Margüello, Mónica | es_ES |
dc.contributor.author | García Hevia, Lorena | es_ES |
dc.contributor.author | Miralles López, Laura | es_ES |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2023-10-19T15:17:05Z | |
dc.date.available | 2023-10-19T15:17:05Z | |
dc.date.issued | 2023 | es_ES |
dc.identifier.issn | 1661-6596 | es_ES |
dc.identifier.issn | 1422-0067 | es_ES |
dc.identifier.other | IJC2020-043746-I | es_ES |
dc.identifier.other | PTQ2018-010019 | es_ES |
dc.identifier.uri | https://hdl.handle.net/10902/30263 | |
dc.description.sponsorship | Funding: This work was partially funded by ‘Formulación de bacteriófagos como liposomas y nanopartículas con aplicación potencial al tratamiento de infecciones de pacientes de fibrosis quística’, from Mutua Madrileña, and ‘Desarrollo de nuevos procedimientos diagnósticos del coronavirus SARS-CoV-2 mediante técnicas de amplificación isotérmica’, from the Instituto de investigación Valdecilla (IDIVAL) (reference INNVAL 20/22). Lorena García-Hevia wants to thank the Ministry of Innovation and Science of Spain for her Juan de la Cierva Incorporación grant (IJC2020-043746-I). Laura Miralles wants to also thank the Ministry of Innovation and Science of Spain for her Torres Quevedo grant (2018–2022) (PTQ2018-010019).
Acknowledgments: Figures have been created with BioRender software (BioRender.com, License ID: 9519A1C8-0002). | es_ES |
dc.format.extent | 22 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | International Journal of Molecular Sciences, 2023, 24, 10233 | es_ES |
dc.subject.other | COVID-19 | es_ES |
dc.subject.other | Diagnosis | es_ES |
dc.subject.other | Clinical management | es_ES |
dc.subject.other | Device integration | es_ES |
dc.subject.other | Nanomedicine applications | es_ES |
dc.title | Detection of SARS-CoV-2 based on nucleic acid amplification tests (NAATs) and its integration into nanomedicine and microfluidic devices as point-of-care testing (POCT) | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.3390/ijms241210233 | es_ES |
dc.type.version | publishedVersion | es_ES |